Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study
Sign Up to like & getrecommendations! Published in 2018 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s150550
Abstract: Objective Riluzole is the first drug approved to treat amyotrophic lateral sclerosis (ALS). Recently, an oral suspension (OS) of riluzole was made available. Thus, the aim of our study was to evaluate the adherence to… read more here.
Keywords: group; adherence riluzole; amyotrophic lateral; riluzole ... See more keywords